CCR News Archives
CCR News Archives
2020
- Phase I CAR T-cell therapy leads to years-long remissions in relapsed B-cell lymphoma patients
- Clinical trial tests immunotherapy combination for advanced HPV-associated cancers
- Clinical trial tests vaccine for late-stage HPV-linked tumors
- Lymphoma therapy drug tested as early treatment for chronic graft-versus-host disease
- Ira Pastan receives 2020 Paul A. Volcker Career Achievement award
- Ruth Nussinov and Kandice Tanner named American Physical Society Fellows
- Jordan Meier receives the 2021 Eli Lilly Award in Biological Chemistry
- Sue Wickner receives the 2021 American Society for Microbiology Award for Basic Research
- Combination therapy for solid tumors and small-cell cancers studied in new clinical trial
- Clinical trial studies combination immunotherapy for colorectal cancer
- Registration Open: Enhancers, Gene Regulation and Genome Organization
- Selumetinib offers hope as first FDA-approved treatment for neurofibromatosis 1 (NF1)
- Clinical trial evaluates a combination therapy for metastatic clear cell renal carcinoma
- In Memoriam: Larry K. Keefer, Ph.D.
- Clinical trial evaluates immunotherapy for head and neck cancer caused by HPV
- Trial opens to evaluate a potential anti-metastasis compound
- Clinical trial will evaluate chemotherapy-sparing approach to treating Kaposi sarcoma
- Undergraduate research at NCI sparks curiosity and new connections
- Innovative imaging tools reveal how neutrophils fight inflammation in mice
- FDA grants rare pediatric disease designation for experimental immunotherapy for acute lymphoblastic leukemia
- In mice, new therapeutic strategy enhances the effects of immunotherapy in high ASS1-expressing cancers
- Experimental compound blocks SARS-CoV-2’s ability to infect and kill cells in the lab
- Epigenetic marker contributes to PARP inhibitor resistance
- New synthetic compounds alter RNA expression in bacteria
- A Conversation with Adam Sowalsky, Ph.D.
- Clinical trial evaluates radiopharmaceutical as therapy for biochemically recurrent prostate cancer
- Immunotherapy clinical trial tests therapy for metastatic solid tumors
- Two patient’s stomachs kept “alive” after removal in novel study to understand stomach cancer
- Joe Chinquee volunteers with Navajo Nation during COVID-19 pandemic
- In Memoriam: Flossie Wong-Staal, Ph.D.
- Lieutenant and Research Nurse Matt Lindsley shares his experiences and public service role
- Mary Kearney discusses coronavirus with National Geographic
- Clinical trial tests combination therapy for glioblastoma multiforme
- In Memoriam: Gilbert Howlett Smith, Ph.D.
- Sarcoma Awareness Month
- Trial shows aggressive cancer treatment is appropriate for people with HIV-associated primary central nervous system lymphoma
- Study finds drug beneficial for shrinking mesothelioma tumors
- Clinical trial studies combination therapy for certain mature T-cell cancers that have not responded to treatment
- Clinical trial tests targeted radioactive agent as therapy for metastatic prostate cancer
- A Conversation with Christina Annunziata, M.D., Ph.D.
- New chemical sequencing reaction helps unravel the role of an ancient RNA modification
- Clinical trial studies CAR T-cell therapy for relapsed/refractory acute myeloid leukemia
- New clinical trial evaluates chemotherapy delivery for stomach cancer
- CCR presentations at AACR 2020 - Session II
- CCR scientists develop new blood test that may improve liver cancer screening
- In Memoriam: Isaiah Fidler, D.V.M, Ph.D.
- A Conversation with Bríd Ryan, Ph.D., M.P.H.
- Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
- FDA approves pomalidomide for AIDS-related Kaposi sarcoma
- In Memoriam: Stephen Oroszlan, Ph.D.
- Eytan Ruppin quoted in New York Times story on treating COVID-19
- Ira Pastan selected as a 2020 Sammies finalist
- John Schiller elected to the National Academy of Sciences
- NCI initiative aims to boost CAR T-cell therapy clinical trials
- Andrea Apolo receives Arthur S. Flemming Award
- Dr. William Dahut discusses coronavirus and cancer patients on Frankly Speaking about Cancer podcast
- The discovery of selumetinib for children with NF1
- FDA approves first therapy for children with neurofibromatosis type 1
- New genetic analysis will help researchers understand how diffuse large B-cell lymphoma subtypes respond to experimental therapies
- Mouse models and patient data suggest potential biomarker for immunotherapy response in melanoma
- In Memoriam: Nancy Colburn, Ph.D.
- CCR researchers show selumetinib shrinks tumors in children with NF1
- New Milestones publication now available
- CCR researchers show testing with combined biopsy method improves prostate cancer diagnosis
- Christian Hinrichs and Steve Rosenberg receive Federal Laboratory Consortium award
- A new set of genes linked to metastasis in melanoma
- Clinical trial studies combination therapy for mesothelin-expressing solid tumors
- Irinotecan shrinks DNA-repair-deficient breast cancers in patient-derived mouse models
- Udo Rudloff and team develop potential new type of immunotherapy
- New study overturns conventional understanding of how HIV infection occurs
- Jennifer Brudno and James Kochenderfer discuss reduced side effects of remodeled CAR T-cell therapy
- Potent new LDHI inhibitor disrupts tumor growth in mice
- Researchers identify protein essential for assembling cells’ energy-producing machine
- New tool catalogs thousands of previously unknown viruses
- James N. Kochenderfer receives Top Ten Clinical Research Achievement Award
- Clinical trial tests combination immunotherapy for genitourinary tumors
- T-cell stimulation could be used to target cancers with common TP53 gene mutations
- New technology elucidates how metabolites interact with proteins to drive cancer
- Side effects of CAR T-cell therapy are dramatically reduced with new receptor
- Now recruiting: Combination therapy clinical trial for small-cell lung or small-cell extrapulmonary cancers
- Genomic profiles of lung cancer differ based on ancestry
- Clinical trial investigates IV administration of vaccine for advanced solid tumors
- FDA grants orphan drug designation to zotiraciclib for the treatment of glioma
- FDA grants orphan drug designation to zotiraciclib for the treatment of glioma
- Protein affecting cell division hints at a way to overcome drug resistance
- Jay Berzofsky and Hoyoung Maeng discuss new vaccine to help men with prostate cancer
- Former Pediatric Oncology Branch patient donates toys to NIH Pediatric Clinic
2019
- Binding preferences of Ras and Raf yield clues for developing targeted cancer therapies
- Histone deacetylase inhibitors block cancer-driving gene networks by obstructing DNA folding
- Differences between anti-viral and anti-tumor T-cell responses could impact immunotherapy
- Differences between anti-viral and anti-tumor T-cell responses could impact immunotherapy
- New findings hint at therapies for African Americans with lung cancer
- Christopher Buck recently featured in Nature Index article
- Ronald Gress discusses therapeutic potential of supercentinarian immune cells
- Martha Zeiger elected President of the American Thyroid Association
- Newest Lasker Scholars Nirali Shah and David Takeda featured in Intramural Research Program blog
- POSTPONED: RNA Imaging and Intracellular Dynamics Workshop
- POSTPONED: 3rd NCI Symposium on Cancer Health Disparities
- Jonathan Hernandez named one of Washington, D.C.’s best doctors
- Unlocking the key to HIV persistence